Doctor profile · Federal record
Dr. David Vanderweele, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Chicago, IL
- NPI 1689846834
- Accepts Medicare
- MIPS 90.0 / 100 · 2023
- 19 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
676 N Saint Clair St Ste 850
Chicago, IL 60611
(773) 111-8972 - Additional location
-
10 Center Dr
Bethesda, MD 208920001
(301) 319-2919
fax (301) 319-2901 - Mailing address
-
680 N Lake Shore Dr Ste 1000
Chicago, IL 606118709
Credentials & registration
- NPI registered
- March 2008 — 18 yrs on file
- Profile last updated
- July 19, 2018
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Illinois #036123890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689846834. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
43,641
Distinct HCPCS
10
Medicare allowed
$1,266,626
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 9,180 | 43 | $23 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,020 | 22 | $48 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,800 | 16 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,950 | 23 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 4,102 | 11 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 2,400 | 12 | $0 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,870 | 15 | $45 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,459 | 18 | $29 | |
J0461 |
Injection, atropine sulfate, 0.01 mg | 1,060 | 17 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,044 | 21 | $6 |
In context: peer comparison
Among 25 peers in Chicago Medical Oncology Physician, average services per provider: 1,025. This provider delivers 43× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
462
Patients
82
Total drug cost
$1,049,715
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Abiraterone Acetate | Generic | 168 | 32 | $310,935 |
| Prednisone | Generic | 141 | 38 | $1,264 |
| Orgovyx (Relugolix) | Brand | 34 | 0 | $87,408 |
| Tamsulosin Hcl | Generic | 34 | 12 | $791 |
| Xtandi (Enzalutamide) | Brand | 29 | 0 | $415,070 |
| Nubeqa (Darolutamide) | Brand | 17 | 0 | $233,114 |
| Hydrochlorothiazide | Generic | 15 | 0 | $44 |
| Oxybutynin Chloride ER (Oxybutynin Chloride) | Brand | 13 | 0 | $907 |
| Dexamethasone | Generic | 11 | 0 | $183 |
Hospital affiliations
Frequently asked questions
What is Dr. David Vanderweele's medical specialty?
Dr. David Vanderweele practices Medical Oncology Physician in Chicago, IL.
Where does Dr. David Vanderweele practice?
Dr. David Vanderweele practices at 676 N Saint Clair St Ste 850, Chicago, IL 60611. Office phone: 7731118972.
What is Dr. David Vanderweele's NPI?
Dr. David Vanderweele's National Provider Identifier (NPI) is 1689846834, issued by NPPES.
Does Dr. David Vanderweele accept Medicare assignment?
Yes. Dr. David Vanderweele accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Vanderweele commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.